CHICAGO – In the wake of its largest fundraising round to date, a $110 million Series F, Sophia Genetics is looking to both expand and consolidate.
The expansion is geographic, with the Swiss-American bioinformatics company eyeing new markets in the US and Asia. The consolidation, meanwhile, refers to using its core technology platform to bring together multiple data types to enable clinicians to tap into what the company calls "data-driven medicine."
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
